Apyx Medical Corp — Director's Dealing 2021

Feb 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Apyx Medical Corp (APYX)
CIK: 0000719135
Period of Report: 2021-01-29

Reporting Person: Semb Tara (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-29	Stock Option (Option to Buy)	$9.29	A	48000	Acquired	2031-01-29	Common Stock (48000.0)	Direct

Footnotes

F1: Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.